Organizations shaping AI

Isomorphic Labs

Alphabet drug-discovery company spun out of DeepMind, applying AlphaFold-style AI to pharmaceutical research.

Xaira Therapeutics

AI-native drug-discovery company launched with over $1 billion in initial funding. Led by CEO Marc Tessier-Lavigne (former Genentech chief scientific officer) and co-founded by protein-design pioneer David Baker, combining generative models with wet-lab drug development.

Genentech

Genentech is a biotechnology company founded in South San Francisco, a pioneer of recombinant-DNA medicine; it is now a member of the Roche Group.

Inceptive

Biotech startup applying deep learning to design RNA molecules and programmable medicines.

Lila Sciences

Startup applying AI to scientific discovery and autonomous laboratories.

Chai Discovery

AI biology company building foundation models for molecular structure prediction and drug-discovery workflows.

Insilico Medicine

Drug-discovery company applying generative AI to longevity and disease research.

Latent Labs

AI-for-biology startup founded by Simon Kohl (formerly of Google DeepMind), building generative models for protein design.

Owkin

"Building the one AI Scientist, purpose-built for biomedical breakthroughs."

Altos Labs

Altos Labs develops cellular-rejuvenation therapies through partial epigenetic reprogramming, aiming to reverse disease by restoring cell health and resilience.

ApSTAT Technologies is a Montreal-based AI and data science firm founded in 2001 by Yoshua Bengio and several of his graduate students, originally focused on statistical forecasting and data mining across insurance, finance, and biomedical domains.

Astex Therapeutics (now Astex Pharmaceuticals) is a Cambridge, UK-based drug discovery company founded in 1999, pioneering fragment-based drug discovery; it is a wholly owned subsidiary of Otsuka Pharmaceutical and has contributed to three approved cancer drugs.

Atomic AI

Biotechnology company combining machine learning, structural biology, and experimental assays to predict RNA structure and develop RNA-targeted medicines.

Bioptimus is a Paris-based AI biology company that is building foundation models for biology to advance drug discovery and biological research.

ChronicleBio

Builds longitudinal, multimodal biological datasets and models for studying complex chronic and neuroimmune conditions, connecting patient histories, molecular measurements, and real-world clinical data.

Columbia Engineering (the Fu Foundation School of Engineering and Applied Science) is Columbia University's engineering school, founded in 1864 in New York City as the School of Mines and now one of the oldest engineering schools in the United States, with programs spanning computer science, electrical engineering, biomedical engineering, and applied mathematics.

Deep-learning research and consulting outfit led by Dan Cireșan, a pioneer of multi-column deep neural networks and former researcher at the Swiss AI lab IDSIA. Works on neural networks and biomedical image analysis.

Dutch–Swiss biotech company founded in 2021 by Stef van Grieken, formerly of Google, and colleagues. Builds machine-learning software for protein engineering, using language models to help scientists design better proteins with fewer experiments.

Denali Therapeutics is a biotechnology company developing medicines for serious diseases affecting the brain and body. Its work centers on barrier-crossing biologics, including its TransportVehicle platform for delivering therapies across biological barriers such as the blood-brain barrier.

An interdisciplinary research institute combining AI, science, education, and commercial development to pursue advances in health, biology, food security, climate, economics, and robotics.

EvolutionaryScale

Frontier AI-for-biology research lab founded in 2024 by former Meta researchers Alexander Rives, Tom Sercu, and Sal Candido. Builds the ESM family of protein language models, including ESM3, which can generate novel proteins.

Foresite Capital is a healthcare and life-sciences investment firm using a data-science-driven approach to back companies at the intersection of biology, medicine, and big data. Its network is relevant to AI-enabled drug discovery, diagnostics, and computational biology startups.

Foresite Capital incubator and venture studio focused on data-driven healthcare and life-sciences company creation.

Nonprofit building AI agents to automate research in biology and other complex sciences.